Trial intelligence / Profile preview

Phase 3 trial of other antiallergic agent in Japan

jRCT2080224004Phase 3Completed

Start
Aug 2018
01

Overview

Phase 3 trial in allergy. Started Aug 2018; status: completed.

02

Conditions

allergy

Beyond the preview

Go deeper on jRCT2080224004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080224004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call